Rasmus Haunstrup Døssing on Muck Rack

Rasmus Haunstrup Døssing

As seen in: European Journal of Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rasmus Haunstrup

Contact Rasmus Haunstrup, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Corrigendum to “Discontinuation of BRAF/MEK inhibitor therapy after long-lasting response: Clinical outcomes in advanced melanoma” [Eur J Cancer 234 (2026) 116200]

|
By Anna Clausen, Rasmus Haunstrup Døssing, Elisabeth Hesselberg
| European Journal of Cancer Verified
The authors regret for the following mistakes: 1) P value reported in the text (3.2 Survival Outcomes) as “Among patients who discontinued therapy (n = 37) the median OS from treatment initiation was 125 months, compared to 79 months in the continued group (n = 60) (p = 0.0086, 95 % CI: 1.10–2.07; Fig.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified